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Activation of FGFR(IIIc) isoforms promotes
activin-induced mesendoderm development in mouse
embryonic stem cells and reduces Sox17 coexpression
in EpCAM+ cells
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Available online 27 February 2011Abstract Activin induces the formation of definitive endoderm from mouse ES cells dependent on active fibroblast growth
factor (Fgf) signaling. Here we report that Fgf4 is dispensable for activin A-induced differentiation of mouse ES cells into
endoderm. We find that Fgf4−/− cells readily differentiate into definitive endoderm without exogenous administration of Fgf4.
Additionally, we investigate the spatio-temporal dynamics of Fgf receptor (FGFR) isoform distribution in activin A-treated ES
cell cultures and find that FGFR(III)c isoforms are expressed in DE as well as non-DE populations, whereas FGFR2(III)b and FGFR4
are found specifically enriched in the DE fraction. Ligands that preferentially activate the FGFR(III)c isoforms induce
mesendoderm markers T and Gsc, but reduce expression of the DE marker Sox17 in activin-induced EpCAM+ cells. In contrast,
ligands specifically activating FGFR(III)b isoforms have no effect on either population. Activation of FGFR(III)c isoforms results in
a strong mitogenic effect on activin A-induced ES cell progeny early in the differentiation period whereas activation of FGFR(III)
b isoforms has only a moderate mitogenic effect confined to the late differentiation period. We conclude that FGFR(III)c-
isoform activation selectively drives the differentiation of mES cells toward mesendoderm and that Fgf4 is dispensable for the
differentiation into definitive endoderm.
© 2011 Elsevier B.V. All rights reserved.Introduction
Knowledge obtained from developmental biology can be
used to direct differentiation of mouse embryonic stem
cells (mESC) toward specific germ layers and more mature
tissues. Recently, differentiation into glucose-responsive
beta cell-like insulin-secreting cells has received much⁎ Corresponding author at: Hagedorn Research Institute, Niels
Steensens Vej 6, DK-2820 Gentofte, Denmark. Fax: +45 44438000.
E-mail address: pas@hagedorn.dk (P. Serup).
1873-5061/$ – see front matter © 2011 Elsevier B.V. All rights reserved
doi:10.1016/j.scr.2011.02.003attention since such cells could serve as a cure for type I
diabetes mellitus if implanted into patients (McCall et al.,
2010). For this purpose, the first step is to generate
definitive endoderm (DE) with the potential to further
differentiate into cells resembling the primitive gut tube
(reviewed by (Van Hoof et al., 2009)). Understanding the
role of each component used in this directed differentiation
is crucial for obtaining the optimal progenitor cell
population in each step.
In the late blastocyst stage of the developing mouse
embryo (E4.5), the inner cell mass (ICM) is divided into the
epiblast and the primitive, later visceral, endoderm. The.
263Fgf signalling and mesendoderm differentiation in mES cellsvisceral endoderm (VE) is involved in anterior–posterior
patterning of the epiblast, restricting the domain where
primitive streak (PS) formation can initiate at the posterior
end (reviewed by (Rossant, 2004)). In the gastrulating mouse
embryo, epiblast cells migrate through the PS, and in this
process become determined toward either mesoderm or DE
(Tam et al., 1993; Lawson et al., 1991; Carey et al., 1995).
The transforming growth factor-β family member nodal, an
activator of Smad2/3 signaling, is the main initiator of
epiblast patterning and PS formation (Waldrip et al., 1998;
Conlon et al., 1994). At high levels, nodal induces anterior
PS structures and DE and at low doses it induces more
posterior streak fates (Ben-Haim et al., 2006). Close to the
posterior-most end of the PS, bone morphogenetic protein 4
(BMP4) is produced by the extraembryonic ectoderm and
establishes a signal gradient. BMP4 is critical for formation
of the PS and induces mesoderm formation (reviewed by
(Gadue et al., 2005)). It is believed that meso- and
endodermal cells arise from a common progenitor cell
population, the mesendoderm (Lawson et al., 1991; Kinder
et al., 2001). Brachyury (T) is expressed in the PS as well as
in nascent mesoderm of the mouse embryo (Kispert and
Herrmann, 1994). Goosecoid (Gsc) is expressed in the
anterior streak, from which the DE arises (Blum et al.,
1992). Gsc is induced by high concentrations of activin A
(activin hereafter) in animal cap explants from Xenopus and
in mES cells Gsc expression is used as a marker of an anterior
mesendoderm-like population (Gadue et al., 2006; Kubo et
al., 2004). Sry-related HMG box gene 17 (Sox17) is an early
marker expressed in the definitive endoderm of the
gastrula, and later expands to the endoderm underlying
the neural plate of the early-bud-stage embryo (Kanai-
Azuma et al., 2002). Sox17 is also expressed in the
extraembryonic visceral endoderm.
InmESC cultures, cells take on amesendodermal fate before
being committed to either mesoderm or DE (Tada et al., 2005).
Activin is used as a surrogate for nodal as they both activate
Smad2/3 signaling via activation of the Alk4 receptor (Schier,
2003). In the mesendoderm population, high concentrations of
nodal/activin-signaling induce anterior streak andDE cells while
BMP4 or low concentrations of nodal/activin induce posterior
streak and mesoderm (Kubo et al., 2004; Hansson et al., 2009;
Willems and Leyns, 2008). The PS genes T, Mix-like 1 (Mixl1),
and Gsc are expressed in this population in response to
increasing concentrations of activin. High activin levels further
induce the DE markers Sox17, Cadherin1 (Cdh1 (E-cadherin)),
and Forkhead box a2 (Foxa2). In contrast, BMP4 induces T,
Mixl1, and the mesodermal marker Fetal like kinase 1 (Flk1;
VEGFR2/Kdr; (Gadue et al., 2005)). During mESC differentia-
tion, T-expressing cells give rise to both meso- and endodermal
derivatives (Kubo et al., 2004) and we have previously shown
that a T-GFP reporter cell line (TGfp/+; (Fehling et al., 2003)) is
preferentially activated by BMP4 or by a low concentration of
activin (Hansson et al., 2009).
Fibroblast growth factor (Fgf) signaling is required for the
differentiation ofmesendodermandDE to occur properly inmES
cells (Hansson et al., 2009;Willems and Leyns, 2008; Funa et al.,
2008; Morrison et al., 2008). The Fgf family of proteins consists
of 22 members named Fgf1–23 (Fgf15 is the mouse ortholog of
human Fgf19). They activate one or more of four receptor
tyrosine kinases, the Fgf receptors (FGFR)1–4. FGFR1–3 have
two splice variants in their Ig-like domain III, the FGFR(III)b orFGFR(III)c isoforms (FGFRb or FGFRc hereafter; (Itoh andOrnitz,
2004; Ornitz and Itoh, 2001)). Fgfs are involved in many
functions in the developing embryo such as germ layer
formation, cell proliferation, and cell migration (Ornitz and
Itoh, 2001). In early mouse development, Fgf signaling is
necessary for the migration of epiblast cells through the PS
(Ciruna et al., 1997; Guo and Li, 2007). The loss of Fgf4 is lethal
at Embryonic Days (E)4–5, due to the inability of epiblast cells to
undergo epithelial-to-mesenchymal transition and migrate
through the PS (Feldman et al., 1995). FGFR1−/− mice also die
at gastrulationandboth Fgf4 andFGFR1areexpressed in the ICM
and PS (Yamaguchi et al., 1994; Deng et al., 1994). Fgf4 is
expressed in pluripotent mES cells and has been shown to be
necessary for differentiation into ectoderm and mesoderm
lineages, suggesting a crucial role of Fgf4 in the initiation of
differentiation (Kunath et al., 2007). Nevertheless, previous
work has shown that Fgf4−/− cells can differentiate in vitro,
albeit at a low frequency, and give rise to tumors consisting of a
wide range of differentiated cell types in vivo (Wilder et al.,
1997).
Here we show that ES cells deficient for Fgf4, a potential
FGFRc isoform-activating ligand, were able to differentiate to
definitive endodermcells at levels comparable towt and Fgf4+/−
cells. Furthermore, we extend our previous finding that Fgf
signaling is necessary for DE formation (Hansson et al., 2009),
and investigate the effects of activating different FGFR isoforms
on mesendoderm and DE differentiation. We demonstrate that
FGFRc isoforms are up-regulated in both Sox17+ and Sox17–
populations emerging after activin treatment. By means of
reporter cell lines and immunocytochemistry we find that Fgfs
which preferentially activate FGFRc isoforms augment the
expression of PS and mesendoderm markers T and Gsc and
selectively expand an EpCAM+Sox17− population. In contrast,
Fgfs activating FGFRb isoforms have no effect on the expression
of these markers nor on the expansion of EpCAM+ cells. Fgfs
activating the FGFRc isoforms show the highest mitogenic
effects early in the differentiation period, while proliferation
rates are reduced later in the culture period as expected from
increased contact inhibition at higher cell densities. We
conclude that FGFRc isoforms promote mesendoderm but not
DE formation and that Fgf4 signaling is dispensable for induction
of DE in mES cells.
Results
Fgf4 is dispensable for the formation of endoderm
from mES cells
Fgf4 is important during gastrulation where it is responsible
for the cell's movement through the PS (Bottcher and Niehrs,
2005), and was recently reported to be required for mESC to
leave the pluripotent stage (Kunath et al., 2007). However,
our previous work demonstrated that Fgf signaling is required
only at a late stage (Days 4–5) during activin-induced DE
formation (Hansson et al., 2009). We therefore investigated
whether Fgf4 is required for activin-induced differentiation
of mESCs into the endoderm lineage. Pluripotent Fgf4−/−
mESCs showed different cell morphology than pluripotent
E14 and Fgf4+/− cell lines. Fgf4−/− cells grew in small, very
dense clusters indicative of pluripotent cells (Fig. 1A) and
growth rates were slower than for Fgf4+/− cells, confirming
264 J.M.L. Peterslund, P. Serupthe mitogenic effect of Fgf4 on mESC. Undifferentiated
Fgf4−/− cells stained positive for the pluripotency marker
Oct4 and negative for the endoderm marker Sox17, similar to
the wt and heterozygous cell lines. qPCR analyses revealed 2-
to 3-fold higher expression levels of Nanog and Oct4
compared to wild-type cells in the pluripotent state and
after 5 days of differentiation in activin-supplemented
medium, expression levels of Nanog and Oct4 in the Fgf4+/−
cell line and Fgf4−/− cell line supplemented with Fgf4 wereFigure 1 Fgf4 is dispensable for endoderm differentiation. E14, Fg
endoderm by immune staining and qPCR before onset of differentia
were analyzed by immune cytochemistry (ICC) for Oct4 and Sox17
pluripotency markers Nanog and Oct4 in undifferentiated cells and a
and samples were standardized to the housekeeping gene Tbp. The m
using a Student's t test for the statistical analysis: *P b 0.05; **P b 0.0
(C) Cells were stained for Oct4 and endoderm markers Sox17, Foxa
Representative images are shown for each condition. Scale bars: 10reduced as seen in wt cells. In the Fgf4−/− cell line, Nanog
levels were reduced by approx 50% compared to undiffer-
entiated cells, but Oct4 levels remained almost as high as in
the undifferentiated cells (Fig. 1B), consistent with the
notion that Fgf4 is required for the cells to leave the
pluripotent state. To rigorously test if Fgf4 was required for
endoderm differentiation we treated E14, Fgf4+/−, and
Fgf4−/−mESC with 30 ng/ml activin and examined expression
of the endoderm markers Sox17, Foxa2, and Cdh1 (Kaestnerf4+/−, and Fgf4−/− cells analyzed for markers of pluripotency and
tion and on Day 5 of the DE protocol. (A) Undifferentiated cells
and the nuclear stain DAPI. Scale bars: 100 μm. (B) qPCR for
t Day 5. The relative expression to E14 ESC conditions is shown,
ean expression ± SEM of 3–4 independent experiments is shown,
1 compared with the undifferentiated condition of each cell line.
2, and E-cadherin (Ecad), and DAPI at Day 5 of differentiation.
0 μm.
265Fgf signalling and mesendoderm differentiation in mES cellset al., 1994; Weinstein and Ruiz Test, 1994). Fgf4+/− cells
behaved much like E14 wt cells, showing high numbers of
Oct4–Sox17+ and Sox17+Foxa2+Cdh1+ cells by Day 5 (Fig. 1C).
Remarkably, Fgf4−/− cells treated with activin readily
differentiated along the endoderm lineage, showing mainly
Sox17+Oct4–cells with a few Sox17+Oct4+ cells not seen in
the wild-type and Fgf4 heterozygous cell lines (Fig. 1C), but
we could confirm the lack of neuroectodermal differentia-
tion in Fgf4−/− cells (Fig. S1). Treatment of Fgf4−/− cells with
Fgf4 restored neuroectodermal differentiation and reduced
the number of Oct4+ cells to wild-type levels (Fig. S1 and
data not shown). There were comparable numbers of
Sox17+Foxa2+Cdh1+ cells in the Fgf4−/− cells and wild-type
or heterozygous cell lines, and these did not change by the
addition of Fgf4 to the medium (Fig. 1C). We conclude that
Fgf4 is dispensable for activin-induced differentiation of mES
cells along the endoderm lineage and for mESC to leave the
pluripotent state.
Definitive endoderm is formed in the absence
of Fgf4
To determine if the endoderm formed was of a definitive or
visceral type we analyzed for markers of visceral endoderm:
Sox7 and Thermostable direct hemolysin gene (Tdh) (Sher-
wood et al., 2007), and DE: Sox17, CXC chemokine receptor 4
(Cxcr4), Claudin-6 (Cldn6) and Forkhead box a3 (Foxa3)
(Sherwood et al., 2007; Monaghan et al., 1993; Gadue et al.,
2009). Immune staining of undifferentiated cells showed no
expression of Sox17 or Sox7 at this stage (Fig. 2A), but qPCR
and Western blot analyses revealed some Sox7 mRNA and
Sox7 protein along with a very low expression of Sox17mRNA
and no Sox17 protein (Figs. 2C–E). After 5 days of activin-
induced differentiation the Sox17+ cells that developed from
E14 cells as well as Fgf4−/− and Fgf4+/− cell lines were Sox7–,
indicative of DE formation (Fig. 2B). We further tested for
expression of DE markers in all three cell lines by Western
and qPCR analyses and confirmed expression of Sox17 and
absence of Sox7 (Fig. 2C). At the mRNA level, Sox17, Cldn6,
Foxa3, and Cxcr4 transcription were induced after activin
treatment (Fig. 2C) indicative of the formation of DE rather
than VE. The VE marker protein Sox7 was only present in the
Fgf4−/− cell line at Day 5, and to a much reduced level
compared to the undifferentiated state (Fig. 2C). Notably,
Sox17 was induced at Day 5 in Fgf4−/− cells to levels
comparable to those seen in E14 wild-type cells, Fgf4+/−
cells and Fgf4−/− cells supplemented with exogenous Fgf4.
Sox7 mRNA showed similar levels of expression in the
pluripotent and differentiated states for all three cell lines
(Fig. 2C) and the absolute amount of mRNA was very low,
i.e., similar to Sox17-expression levels in undifferentiated
mES cells. Tdh was expressed at intermediary levels in mES
cells but was down-regulated on DE induction (Fig. 2C). In
summary, we conclude that Fgf4 signaling is dispensable for
induction of DE in Fgf4−/− mES cells.
Expression of Fgf receptor isotypes during definitive
endoderm formation
Although Fgf4 does not appear to be required for activin-
induced DE formation, we and others have shown that Fgfsignaling is necessary for the differentiation of mouse
mESC cultures to definitive endoderm (Hansson et al.,
2009; Willems and Leyns, 2008; Funa et al., 2008;
Morrison et al., 2008). To further understand the
dependence on Fgf signaling during DE formation, we
next examined the expression of FGFR isoforms during a
5-day differentiation period by quantitative RT-PCR
(qPCR). We sorted activin-treated Sox17Gfp/+ cells (Kim
et al., 2007) into Sox17-GFPHi and Sox17-GFPLo fractions,
in order to isolate RNA from the forming DE and the non-
DE populations of cells, respectively (Fig. 3A). In general,
FGFR1c was expressed at high levels, FGFR2b and 2c at
intermediate levels, and FGFR1b, 3c, and 4 at low levels.
During the 5-day differentiation period, FGFR2b and 4
were expressed in the unsorted, Sox17-GFPLo, and Sox17-
GFPHi fractions but their expression was not significantly
different from undifferentiated ES cells (Fig. 3B). FGFR1b
was down-regulated in both the unsorted and Sox17-GFPLo
fractions on initiation of differentiation, although not
significantly different from the undifferentiated culture.
These data are consistent with findings in the mouse
embryo, showing that FGFR2b and 4 are expressed in
endodermal epithelia such as the definitive endoderm
(Orr-Urtreger et al., 1993; Elghazi et al., 2002; Stark et
al., 1991). FGFR1c was up-regulated in the Sox17-GFPLo
fraction alone, peaking on Day 5, whereas FGFR2c and 3c
were up-regulated in both Sox17-GFPLo and Sox17-GFPHi
fractions, on activin-induced differentiation (Fig. 3B). In
summary, FGFRc isoforms are highly up-regulated
throughout the cell culture or in the Sox17-GFPLo fraction
alone, suggesting a role for FGFRc isoform activation as a
modulator of mesendoderm and/or DE formation in
mESCs.FGFR isoform-specific ligands differentially activate
PS and DE markers
Since different Fgfs bind to and activate specific FGFR
isoforms, we speculated that addition of b or c isoform-
specific Fgfs might have different effects on expression of
PS and DE markers in our mESC cultures. We chose to
focus on Fgfs that are described to have a function during
gastrulation and in the development of the DE. Based on
which FGFR they activate (Bottcher and Niehrs, 2005;
Ornitz et al., 1996; Zhang et al., 2006) they were divided
into three categories: Fgf1, 2, and 9 activate a mixed
population of both FGFRb and FGFRc isoforms, with a
preference for the latter; Fgf7 and 10 activate FGFRb
isoforms only; and Fgf4, 5, 6, 8b, 8c, 8e, and 16 activate
one or more FGFRc isoforms and/or FGFR4 (Ornitz et al.,
1996; Zhang et al., 2006; MacArthur et al., 1995; Olsen et
al., 2006; Mason, 2007). FGFR4 is grouped with the FGFRc
type of receptors, as it structurally resembles this group
of FGFRs (Vainikka et al., 1992) and most Fgfs-activating
FGFRc isoforms also activate FGFR4 (Mason, 2007), making
it also functionally FGFRc isoform-like. To evaluate the
effect of the different Fgfs in mesendodermal differenti-
ation, we monitored the expression of PS and DE markers
by means of reporter cell lines on Days 3 and 5.
Accordingly, we treated TGfp/+ cells with 10 ng/ml BMP4
and added different Fgfs to evaluate their effect on
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267Fgf signalling and mesendoderm differentiation in mES cellsBrachyury expression. Fgf1, 2, 4, 6, and 9, binding a
mixed population of FGFRs or FGFRc isoforms only,
increased the number of T-GFP+ cells on Day 3 by up to
20% compared to BMP4 treatment alone, i.e., 78–83±3–4
and 69±6%, respectively (mean %±SD, n=3; Fig. 4A). Fgf7
and 10 had no significant effect on T-GFP induction, nor
did Fgf8b, 8c, 8e, or 16, but Fgf5 slightly repressed T-
induction (Fig. 4A). Looking at the same marker after
treatment with 1 ng/ml activin, we saw that Fgf4 and 6
resulted in a 31–42% increase in the number of T-GFP+
cells on Day 3 (Fig. 4B), while Fgf5, 9, and 10 resulted in
smaller increases. Fgf1, 2, 4, 6, and 9 induced increased
numbers of T-GFP+ cells by up to 34% on Day 5. Fgf7, 8b,
8c, 8e, and 16 showed no effect on the numbers of T-
GFP+ cells on either Day 3 or Day 5. Thus, the largest
effect was seen when adding Fgfs-binding FGFRc isoforms,
which mediated an increase in the measured number of
T-GFP+ cells in general and on Day 5 in particular. This
Fgf-induced increase in Day 5 T-GFP+ cells may be caused
by maintenance of T expression from Day 3 to 5, rather
than by inducing more cells to express T. We next looked
at the effect of Fgf treatment on anterior streak/DE
induction by 30 ng/ml activin in GscGfp/ + mESC (Tada et
al., 2005). Addition of Fgf1, 2, 4, 6, 8b, and 9 increased
the number of Gsc-GFP+ cells by 22–40% (Fig. 4C).
Activation of FGFRb isoforms only, by Fgf7 and 10, had
no effect, nor did Fgf5, 8c, 8e, and 16. This finding was
not due to the lack of cognate receptors, as they were
present in the cell population (Fig. 3B). With the DE
marker Sox17, we observed a 50% decrease of the Sox17-
GFPHi fraction (from 34±4 to 17±3%) when adding Fgfs
activating FGFRc isoforms (Fig. 4D). Treatment with Fgfs
that only activate FGFRb isoforms slightly increased the
number of Sox17-GFPHi cells or had no effect (Fgf7 and
Fgf10, respectively). In summary, Fgf ligands that
predominantly activate FGFR4/FGFRc isoforms, i.e.,
Fgf1, 2, 4, 6, 8b, and 9, promote differentiation toward
a mesendoderm cell population expressing primitive
streak markers but reduce the Sox17+ DE population in
the culture.FGFRc activation suppresses Sox17 expression in
EpCAM+ cells
The reduction in the number of Sox17-GFP+ cells observed
in response to activation of FGFRc isoforms could be the
result of a shift in lineage allocation or a more specific
inhibitory effect on Sox17 expression. To test between
these notions we used triple color flow cytometry to
analyze Sox17-GFP cells labeled with antibodies against
the mesodermal marker Flk1 (Ema et al., 2006) and
EpCAM (epithelial cell adhesion molecule), which isFigure 2 Activin induces DE in the absence of Fgf4. Analyses of DE
differentiation and on Day 5 of the DE protocol. (A) Cells were staine
n=3–4. Representative images are shown. (B) Western blot analysi
representative images are shown. (C) qPCR analyses of VE markers So
relative expression to E14 ESC conditions is shown, and samples
expression±SEM of 3–4 independent experiments is shown, using a
compared to the undifferentiated condition of each cell line. U: undexpressed in pluripotent mES cells, transiently in ecto-
derm, and sustained in the DE epithelium during
embryonic development (Sherwood et al., 2007; Balzar
et al., 1999). Looking at the three markers separately, we
observed a decrease in Sox17-GFPHi cells in the presence
of Fgf1, 2, 4, and 6 in agreement with previous data
(Fig. 5A). Very few Flk1+ cells were formed after activin
treatment, regardless of the Fgf added, but high numbers
of Flk1+ cells were seen in the BMP4-treated samples as
expected (Fig. 5B; (Hansson et al., 2009)). Activin
strongly induced EpCAM+ cells (87±2%) and addition of
Fgfs had no effect on the number of these (Fig. 5C).
However, the number of EpCAM+ cells that expressed
Sox17-GFP was reduced by ~50% after treatment with
Fgf1, -2, -4, and −6 (Fig. 5D). Analysis of EpCAM and Flk1
expression in the Sox17-GFP+ and -GFP− populations
showed that the GFP+ population was uniformly EpCAM
+Flk− while the majority (~80%) of the GFP− population
was EpCAM+Flk− and the remainder (~ 20%) was
EpCAM−Flk1−, regardless of Fgf treatment (Fig. 5E).FGFRc activation stimulates cell proliferation during
the first 3 days of culture
Fgfs were originally discovered as having a mitogenic effect
in fibroblast cells, and were later found to have diverse
effects in embryonic development, including endoderm
formation (Bottcher and Niehrs, 2005; Ornitz et al., 1996;
Gospodarowicz and Moran, 1975). We analyzed the mitogen-
ic effect of the Fgfs in wild-type mESCs on Days 3 and 5, and
found that activin treatment alone gave a ~3-fold increase in
cell numbers by Day 3 (from 2000 cells/cm2 to 6600 cells/
cm2; Fig. 6A). All Fgfs improved cell growth to varying
degrees, Fgf1, 2, 4, and 9 being the most effective (up to 20
400 cells/cm2 or a 3-fold increase compared to the activin-
treated cells at Day 3). We used 5-ethynyl-2′-deoxyuridine
(EdU) incorporation (Salic and Mitchison, 2008) to quantify
the proliferation of cells (see Fig. S2 for gating and controls)
and found that the absolute number of EdU incorporating
cells was 4- to 7-fold higher at Day 3 compared to Day 5, but
treatment with Fgfs did not increase the relative number of
proliferating cells at Day 3 (Fig. 6A). On Day 5, there were
~80 000 cells/cm2 in activin-treated samples. Addition of
Fgf2, which have the largest mitogenic effect in other
systems (Ornitz et al., 1996; Zhang et al., 2006), increased
total cell numbers ~1.6-fold to ~130 000 cells/cm2 (Fig. 6B).
Moreover, treatment with Fgf1, 4, and 6 increased the total
cell number more modestly while other Fgfs did not have any
discernable effect. The reduction in Sox17HiEpCAM+ cells in
relation to total EpCAM+ cells seen after Fgf1, 2, 4, or 6
treatment (Fig. 5D) correlates well with the increase in total
cell numbers and may therefore be explained by theand VE markers in E14, Fgf4+/−, and Fgf4−/− cells before onset of
d for Sox17, Sox7, and the nuclear stain DAPI. Scale bar: 100 μm,
s of Sox7 and Sox17 and the housekeeping protein TFIIB. n=3,
x7 and Tdh and DE markers Sox17, Cxcr4, Cldn6, and Foxa3. The
were standardized to the housekeeping gene Tbp. The mean
Student's t test for the statistical analysis: *Pb0.05; **Pb0.01
ifferentiated cells.
Figure 3 Expression of FGFR isoforms during DE differentiation. The expression of each FGFR isoform was analyzed by qPCR in both
sorted and unsorted fractions of Sox17-GFP cells, differentiated in the presence of 30 ng/ml activin for 5 days. (A) Histogram showing
sorting gates in GFP−, GFPLo, and GFPHi fractions. (B) The relative expression of each FGFR isoform standardized to the housekeeping
gene Tbp. Sox17Hi fractions are shown only at Days 4 and 5, when they appeared in the culture. The number of Sox17-GFP– cells was
too low for RNA extraction. The relative expression (mean±SEM) of 3 independent experiments is shown, using a Student's paired, two-
tailed t test for the statistical analysis: *Pb0.05 compared to the ESC conditions for each fraction (Sox17-GFPHi fractions were
compared to the unsorted ESC sample). U: undifferentiated cells.
268 J.M.L. Peterslund, P. Serupselective expansion of Sox17−EpCAM+ cells. EdU incorpora-
tion at Day 5 revealed a ~67% higher proliferation rate in the
vehicle-treated controls compared to cells treated with
activin (Fig. 6B). Treatment with Fgf1, -2, -4, and −6reduced the number of EdU+ cells by 40–50% while treatment
with Fgf8b, 9, and 10 resulted in more modest reductions.
These data indicate that the main effect seen by Fgf1, 2, 4,
6, and 9 on proliferation occurs prior to Day 3, and that most
Figure 4 Activation of FGFRc isoforms promotes mesendoderm formation and inhibits Sox17 expression. Analyzing GFP-reporter cell
lines T-GFP, Gsc-GFP, and Sox17-GFP, cells were differentiated for 3 (T-GFP cell line only) and 5 days in BMP4 or activin-containing
media±a range of Fgfs. (A and B) T-GFP cells were differentiated in 10 ng/ml BMP4 (A) or 1 ng/ml activin (B)± Fgfs, and expression of
GFP was analyzed by FACS at Days 3 and 5. (C and D) Gsc-GFP cells (C) or Sox17-GFP cells (D) were differentiated in 30 ng/ml
activin±Fgfs, and expression of GFP was measured by FACS at Day 5. The mean expression±SEM of 3 independent experiments is
shown, using a Student's t test for the statistical analysis: *Pb0.05; **Pb0.01 compared to the BMP4 or activin conditions. U,
Undifferentiated cells, Veh., vehicle.
269Fgf signalling and mesendoderm differentiation in mES cellsof the cells in these cultures have left the proliferative state
by Day 5.Discussion
We have previously shown that Fgf signaling augments
differentiation toward PS-like cells and is required at Days 3–5
for efficient differentiation of mESC into DE in response to
activin treatment. However, addition of Fgf2 attenuated
formation of activin-induced Sox17-GFP+ DE cells (Hansson
et al., 2009)), suggesting that levels of signaling must be tightly
regulated. Recently, Fgf4 was shown to be necessary for mESCs
to leave the pluripotent state and differentiate into either
ectoderm or mesoderm lineages (Kunath et al., 2007; Stavridiset al., 2007). Fgf4−/− mESCs could not differentiate into either
lineage, except when supplementing the growth medium with
exogenous Fgf4 protein. Fgf4 is important during gastrulation
where it is responsible for movement of gastrulating cells
through the PS (Bottcher and Niehrs, 2005) and Fgf4 knock-out
mice die during gastrulation (Feldman et al., 1995).
Using culture conditions similar to those Kunath and co-
workers, we found that addition of exogenous Fgf4 was
dispensable when differentiating Fgf4−/− cells into DE by
treatment with activin. We readily obtained Sox17+/E-
cadherin+/Foxa2+/Sox7– DE cells which by qPCR were
shown to express the additional DE markers Cxcr4, Cldn6,
and Foxa3, but not the VE markers Sox7 and Tdh. This
supports our previous finding that induction of DE formation
is not dependent on early Fgf signaling, as cells readily
Figure 5 Activation of FGFRb and FGFRc isoforms differentially affects the expression of DE andmesodermmarkers. Sox17-GFP cells
were differentiated in media containing BMP4 or activin±Fgfs for 5 days before analysis. Cells were stained for markers of DE or
mesoderm and analyzed. (A–C) Sox17Gfp/+ cells stained for Flk1 and EpCAM were analyzed individually for (A) GFP, (B) Flk1, and (C)
EpCAM. (D) Percentage Sox17-GFPHiEpCAM+ cells of the total EpCAM+ population. (E) Multichannel analysis for Flk1 and EpCAM in the
Sox17-GFPHi or Sox17-GFP−/Lo populations. The percentage Flk1−EpCAM+, Flk1+EpCAM+, Flk1−EpCAM−, and Flk1+EpCAM− is indicated.
The mean expression±SEM of 3–4 independent experiments is shown, using a Student's paired, two-tailed t test for the statistical
analysis: *Pb0.05; **Pb0.01 compared to the activin-treated conditions.
270 J.M.L. Peterslund, P. Serupbecome Sox17-GFP+ when the FGFR-inhibitor PD173074 is
present at early stages of differentiation (Hansson et al.,
2009). We propose that exogenous Fgf4 is only necessary for
differentiation into ectoderm and mesoderm lineages but
not for leaving the pluripotent state per se (Kunath et al.,2007; Stavridis et al., 2007). Although Fgf4 knockout mice
have been shown to be embryonic lethal at the stage of
gastrulation (Feldman et al., 1995; Wilder et al., 1997), their
dependence on Fgf4 signaling may lie at an earlier time
point, namely in the area of embryonic ectoderm where later
Figure 6 Activation of FGFRc isoforms affects early cell growth and proliferation. A wt mES cell line, E14, was grown in media
containing activin±Fgfs and harvested for analysis of total cell number and proliferation on Days 3 and 5. An absolute cell number and
the relative proliferation (% EdU+ cells) of cells are shown for Day 3 (A and B) and Day 5 (C and D). The mean expression±SEM of 3
independent experiments is shown, using a ratio t test for absolute cell numbers: #Pb0.05; ##Pb0.01; and a Student's t test for the
relative proliferation: *Pb0.05; **Pb0.01; both compared to the activin conditions.
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formation of the PS rather than its function (Tam et al.,
1993; Niswander and Martin, 1992). This substantiates that
Fgf4 is not necessary for cells to leave the pluripotent state
when the differentiation protocol applied includes activin.
Most studies on endoderm formation from mES cells rely
on culturing conditions using either embryoid bodies as
starting material or high cell densities (Willems and Leyns,
2008; Funa et al., 2008; Morrison et al., 2008). Compared to
Kunath and co-workers, we seed cells at a low density.
Possibly, a high cell density to some degree inhibits
differentiation, a common phenomenon seen in ES cell
differentiation systems. Indeed, when applying the ecto-
derm differentiation protocol as described by Kunath and co-
workers to cells at low density, we saw an increase in neural
differentiation. We speculate that high cell densities retain
mES cells in the pluripotent state to a higher degree than
cells at low densities and that Fgf4 signaling may be
necessary for leaving the pluripotent state at high cell
densities only.
Nevertheless, formation of Sox17+ DE from mESC in
response to activin treatment is influenced by Fgf signaling.
Treatment with the FGFR inhibitor PD173074 at Days 3–5
prevents differentiation of Sox17+ DE but addition of
exogenous Fgf2 also inhibits formation of these cells
(Hansson et al., 2009). Here we find that activation of
FGFRc but not FGFRb isoforms changes the fraction of
EpCAM+ cells that coexpress Sox17. While activin alone
inducs a nearly uniform population of EpCAM+Sox17Hi cells
addition of, e.g., Fgf2 reduces the fraction of EpCAM+ cellsthat coexpress Sox17. This shift may be caused by a selective
expansion of an EpCAM+Sox17− population developing in
response to activin treatment, without affecting the total
number of EpCAM+Sox17+ DE cells. Alternatively, Fgf2 may
inhibit Sox17 expression in a subset of the EpCAM+ cells.
During embryonic development, epithelial tissues generally
express b but not c isoforms while mesenchymal tissues
express mainly c isoforms (Ornitz and Itoh, 2001). Fgfs
specifically activating FGFRb isoforms (e.g., Fgf7 and 10) are
mainly expressed in the mesenchyme and Fgfs activating
FGFRc isoforms (e.g., Fgf4, 8, and 9) are mainly expressed in
epithelia, resulting in specificity during reciprocal epithelial-
mesenchymal signaling in developing organs such as the lung,
cecum, salivary glands, and pancreas (Ornitz and Itoh, 2001;
Orr-Urtreger et al., 1993; Elghazi et al., 2002; Stark et al.,
1991; Colvin et al., 2001; Manfroid et al., 2007). In the
present report we show that both FGFRb and -c isoforms are
expressed in the Sox17-GFPHi fraction after activin treat-
ment. The expression of FGFRb as well as c isoforms in the
Sox17-GFPHi fraction may be explained if the Sox17-GFPHi
fraction is heterogeneous and contains a pool of cells slated
to become DE but not yet committed to an epithelial fate or
cells that are undergoing mesodermal differentiation.
However, the Sox17-GFPHi fraction is also positive for
EpCAM, indicating that they represent epithelial endoderm.
When factors capable of activating the c isoforms for the
FGFRs are added to the activin induction we still observe the
formation of EpCAM+ cells but the percentage of these
coexpressing Sox17-GFPHi is reduced. These cells may
represent undifferentiated ES cells, but we consider this
272 J.M.L. Peterslund, P. Serupunlikely as activin-induced expression of the early mesendo-
derm markers T and Gsc is enhanced by FGFR c-isoform
ligands and the concomitant reduction in Oct4 expression is
not affected. Alternatively, the EpCAM+Sox17− cells may
represent endoderm which has yet to activate Sox17
expression or alternatively have passed through the transient
Sox17-expressing phase. Regardless of their true identity,
this EpCAM+Sox17− population appears to be selectively
expanded by Fgfs that activate the c isoforms for the FGFRs,
although the precise mechanism causing this change remains
to be determined. Examining EpCAM and Sox17-GFP at later
time points as well as qPCR analyses of purified cell
populations could determine if Fgf signaling is delaying the
kinetics of development of EpCAM+Sox17Hi DE cells.
Fgfs activating only FGFRb isotypes had no effect on the
number of EpCAM+Sox17-GFPHi cells developing in response
to activin or on the number of EdU-incorporating cells.
Since FGFR inhibitors reduce the numbers of Sox17-GFPHi
cells (Hansson et al., 2009) we suspect that endogenous Fgf
signaling is sufficient and therefore the further addition of
b-isoform-specific factors has no effect. A putative
endogenous Fgf may be Fgf3, which is expressed in the
PS during gastrulation and which only activates FGFRb
isoforms (Ornitz et al., 1996; Zhang et al., 2006; Wilkinson
et al., 1988). Alternatively, induction of EpCAM+Sox17-
GFPHi cells may rely on precise levels of FGFRc signaling
and increasing this signaling by addition of exogenous Fgf2
may be detrimental to formation of EpCAM+Sox17-GFPHi
cells. The FGFR1b and -2b expression we observe may
render the cells competent to respond to signals occurring
later during organogenesis. Optimal induction of DE may be
supported by a combination of factors, with initial
activation of FGFRc isoforms during early differentiation
to promote mesendoderm formation followed by a second
step where activation of FGFRb isoforms maintains defin-
itive endoderm.Materials and methods
Cell culture and differentiation of mESCs
We used the following mouse ES cell lines: E14 (Hooper et
al., 1987), TGfp/+ (Fehling et al., 2003), GscGfp/+ (Tada et
al., 2005), Sox17Gfp/+ (Kim et al., 2007), Fgf4+/−, and
Fgf4−/− ES cells (Wilder et al., 1997). Cells were grown as
previously described (Hansson et al., 2009; Ying et al.,
2003) on cell culture plastic ware (Nunc) coated with 0.1%
gelatine (Sigma), using 0.05% trypsin-EDTA (Invitrogen) for
dissociation of cells during passage. Trypsin was inacti-
vated by N2B27 medium: KO-DMEM supplemented with N2,
B27, 0.1 mM nonessential amino acids, 2 mM L-glutamine,
penicillin/streptomycin (all from Invitrogen), and 0.1 mM
2-mercaptoethanol (Sigma-Aldrich). Cells were cultured for
at least 3 passages, i.e., 6 days, before onset of
differentiation.
For differentiation purposes, cells were dissociated into
single cells and seeded at 2000 cells/cm2 in N2B27 medium
containing one or more of the following growth factors: BMP4
(10 ng/ml), activin A (1 or 30 ng/ml; both from R&D
Systems), Fgf1 (100 ng/ml; Chemicon International), Fgf2
(100 ng/ml; Invitrogen), Fgf4, Fgf5, Fgf6, Fgf7, Fgf8b, Fgf8c,Fgf8e, Fgf9, Fgf10, and FGF16 (5 or 100 ng/ml; all from R&D
Systems). Media containing Fgfs were supplemented with
10 μg/ml heparan sulfate (Sigma-Aldrich).
Flow cytometry
For analysis of GFP expression in reporter cell lines, live cells
were dissociated into single cells by 0.05% trypsin-EDTA
(Invitrogen) and analyzed by FACS Calibur flow cytometer
(BD Biosciences). For analysis of cells stained with anti-
bodies, cells were fixed in Lilly's fixative (Bie & Berntsen),
and resuspended in 0.1% BSA in PBS. Cells were stained in
0.1% BSA in PBS for 2 h at 4 °C with anti-Flk1-PE (BD
Pharmigen, No. 555308) and anti-EpCAM-PE-Cy7
(eBioscience, No. 25-5791-80). Alternatively, cells were
permeabilized in dilution buffer (0.3% Triton X-100+0.1%
BSA in PBS); unspecific binding sites were blocked by 10%
Normal Donkey Serum (Jackson Immunoresearch Laborato-
ries) for 30 min at RT and stained for Brachyury (R&D
Systems, No. AF2085) for 2 h at RT in dilution buffer,
followed by a Cy3-conjugated secondary antibody (Jackson
Immunoresearch Laboratories, No. 705-165-147) for 1 h at
RT. Cells were analyzed by FACS Aria flow cytometer (BD
Biosciences). For sorting experiments the cells were disso-
ciated by 0.05% trypsin-EDTA (Invitrogen), washed, and
resuspended in N2B27 medium before sorting by FACS Aria
flow cytometer (BD Biosciences).
Immunofluorescent staining
Cells were grown in 9 cm2 slide flasks (Nunc) coated with
0.1% gelatine (Sigma) and fixed in Lilly's fixative (Bie &
Berntsen), permeabilized in dilution buffer (see above), and
blocked for 30 min at RT in 10% Normal Donkey Serum
(Jackson Immunoresearch Laboratories) in dilution buffer.
They were stained overnight at 4 °C with primary antibodies:
mouse anti-Oct3/4 (C-10), goat anti-Foxa2 (both Santa Cruz
Biotechnology), goat anti-Brachyury (R&D Systems), rat anti-
E-cadherin (Zymed/Invitrogen), goat anti-Sox17 (R&D Sys-
tems), and rabbit anti-Sox7 (ab22584, Biozol). After several
washes the cells were incubated for 1 h with Cy2-, Cy3-, or
Cy5-conjugated species-specific secondary antibodies (Jack-
son ImmunoResearch Laboratories) to visualize expression
and 4′,6-diamidino-2-phenylindole (DAPI; MP Biomedicals)
was used as counter stain. Slides were mounted in
fluorescent mounting medium (KPL). Negative controls,
where the primary antibodies were omitted, were included
for all stains and showed no unspecific staining of the
secondary antibodies (data not shown). The slides were
analyzed using an LSM 510 META laser scanning microscope
(Carl Zeiss).
qPCR
Cells were harvested in lysis solution (Invitek), supplemented
with 10 mM dithiothreitol (DTT). Total RNA was isolated using
the Invisorb Spin RNA kit (Invitek) with DNAse treatment
(Promega) following the manufacturer's protocol. cDNA was
prepared from 250 ng RNA using MMLV reverse transcriptase
(Invitrogen) with random oligos or oligo(dT)12–18 primers
(both Invitrogen). qPCR was performed using the standard
273Fgf signalling and mesendoderm differentiation in mES cellsSYBR Green program with dissociation curve on Mx3005P
(Stratagene). PCR were run in duplicates using 10 μl Brilliant
SYBR Green qPCR Master Mix (Stratagene), 1 μl cDNA, 1 μl
20 μM primer mix, and 8 μl dH2O. Quantified values for each
gene were normalized against the housekeeping gene TATA-






CAGGTATAC (all from (Woei Ng et al., 2007); FGFR1b
F_CTTGACGTCGTGGAACGATCT, R_CACGCAGACTGGT-
TAGCTTCAC (Nakayama et al., 2007); FGFR2b F_AACGG-
GAAGGAGTTTAAGCAG, R_GGAGCTATTTATCCCCGAGTG
(Yamanaka et al., 2000); Nanog F_CTCTTCAAGGCAGCCCT-




GACCGCCTTT, R_ AGACCCACCATTATATGCTGGAA (Kim
et al., 2008); FoxA3 F_GGA ACA TGT TTG AGA ACG GCT,
R_CGA TGT GGC GCT GTT TCC TTT (Gadue et al., 2009);
Cldn6 F_TATCCTGTCCCAGTCCCAAG, R_CAGGGCTGGAGA-
GAAGTCTG (Nakazawa et al., 2008); Sox7 F_GGCAGTGCA-
GAACCCGGACC, R_TGCAGAGGCGCTTGCCTTGT; Tdh F_
CCTGGAGGAGGAACAACTGACTA, R_ ACTCGAATGTGCCGTT-
CTTTG (Wang et al., 2009); TBP F_TCTGAGAGCTCTGGAA-
TTGT, R_GAAGTGCAATGGTCTTTAGG.
Cell count and proliferation assay
Cellswere fixed in Lilly's fixative (Bie&Berntsen) and counted in
a NucleoCassette by the NucleoCounter (ChemoMetec A/S)
according to the manufacturer's protocol. For the proliferation
assay, EdU incorporation by the Click-iT EdU HCS Assay
(Invitrogen) was used (Salic and Mitchison, 2008). Cells were
incubated for 15 min in their respectivemedia containing 10 μM
EdU, then washed, fixed, and stained by the Click-iT reaction
cocktail according to the manufacturer's protocol, using an
Alexa Fluor 488-conjugated antibody to detect incorporation.
Stained cells were quantified using a FACS Aria flow cytometer
(BD Biosciences).
Western blot
Total cell lysates were harvested at experimental onset and
Day 5 of differentiation using Cell Lysis Buffer (Cell Signaling
Technology). Twenty micrograms of each protein sample was
loaded and analyzed by Western blot on PVDF membranes
using rabbit anti-Sox7 (ab22584, Biozol), goat anti-Sox17
(R&D Systems), or TFIIb (C-18; Santa Cruz) as primary
antibodies and HRP-conjugated goat anti-rabbit or donkey
anti-goat secondary antibodies (both Santa Cruz
Biotechnology).
Statistics
Mean percentage of the cells of interest±standard error of
the mean (SEM) was calculated and statistical analyses byStudent's paired, two-tailed t test or ratio t test were
performed.
Supplementary data associated with this article can be
found, in the online version, doi:10.1016/j.scr.2011.02.003.
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